InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Parker Albert P, Directeur Juridique. Insider active across 1 company, notably Zynerba Pharmaceuticals, Inc.. Cumulatively, 6 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €2k. Activity tracked since 14 February 2022. The latest transaction was disclosed on 15 February 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Parker Albert P is Directeur Juridique and is associated with Zynerba Pharmaceuticals, Inc. on XNAS as Chief Legal Officer. The declarant has 6 filings in total, and across the recent sampled filings covered from 2022-02-15 to 2023-10-11, the stated amounts are 0 EUR of buys and 1601 EUR of sells, with the modal transaction nature shown as Attribution.